Leiden University Medical Centre – LUMC is a university medical centre for research, education and patient care with a high quality profile and a strong scientific orientation. It has a unique research practice, ranging from pure fundamental medical research to applied clinical research.
LUMC is a centre for medical innovation, committed to the advancement of healthcare and education in line with the latest international insights and standards, and aims to play a nationally and internationally recognized leading role in improving medicine and the quality of healthcare.
LUMC is successful in obtaining funding from external resources such as the European Commission. LUMC is active in 88 granted H2020 projects. LUMC has ample experience with the legal and financial administration of European research projects.
LUMC provides expert referral care for Parkinson’s Disease (PD) and Huntington’s Disease (HD). The HD research team has participated in multiple international observational studies, as well as many clinical trials and investigator-initiated European HD studies.
Main tasks in the project
LUMC will fulfil its tasks within WP6. The main role of LUMC will be to recruit HD patients and healthy controls for the clinical validation study (Task 6.5) (current recruitment plan of 35 patients and 10 healthy volunteers). Moreover, LUMC will coordinate study management at the site, ensuring compliance and principles of GCP during conduct of the study (Tasks 6.2 and 6.3).
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.